POLEMBRA Trademark

Trademark Overview

On Friday, May 7, 2021, a trademark application was filed for POLEMBRA with the United States Patent and Trademark Office. The USPTO has given the POLEMBRA trademark a serial number of 90696775. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Monday, September 16, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The POLEMBRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of pain
polembra

General Information

Serial Number90696775
Word MarkPOLEMBRA
Filing DateFriday, May 7, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateMonday, September 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, metabolic, hematological, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Tuesday, May 11, 2021NEW APPLICATION ENTERED
Monday, August 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022ASSIGNED TO EXAMINER
Tuesday, January 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 13, 2022SOU EXTENSION 1 FILED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 13, 2022SOU EXTENSION 1 GRANTED
Friday, March 31, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU EXTENSION 2 FILED
Friday, March 31, 2023SOU EXTENSION 2 GRANTED
Tuesday, April 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2024SOU EXTENSION 4 FILED
Monday, April 8, 2024SOU EXTENSION 4 GRANTED
Monday, April 8, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 10, 2023SOU EXTENSION 3 FILED
Tuesday, October 10, 2023SOU EXTENSION 3 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 16, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 17, 2024SOU EXTENSION 5 FILED
Tuesday, September 17, 2024SOU EXTENSION 5 GRANTED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

polembra pharmaceutical treatment preparations hepatological nephrological infectious allergic autoimmune respiratory disorders